Proteomic Landscape of Cholangiocarcinomas Reveals Three Different Subgroups According to Their Localization and the Aspect of Non‐Tumor Liver-Reference-Cited by-同舟云学术

Proteomic Landscape of Cholangiocarcinomas Reveals Three Different Subgroups According to Their Localization and the Aspect of Non‐Tumor Liver

Published:2018-12-19 Issue:1 Volume:13 Page:1800128
ISSN:1862-8346
Container-title:PROTEOMICS – Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Le Faouder Julie¹^ORCID,Gigante Elia¹²,Léger Thibaut³,Albuquerque Miguel⁴,Beaufrère Aurélie⁴,Soubrane Olivier⁵,Dokmak Safi⁵,Camadro Jean‐Michel³,Cros Jérôme¹⁴,Paradis Valérie¹⁴

Affiliation:

1. Paris Diderot UniversitySorbonne Paris Cité CRI, UMR 1149, Inserm Clichy F‐92110 France

2. Hepatology and Gastroenterology DepartmentSaint‐Antoine HospitalSorbonne University Paris F‐75012 France

3. Mass Spectrometry LaboratoryJacques Monod InstituteUMR 7592Paris Diderot University CNRS, Sorbonne Paris Cité F‐75205 Paris Cedex 13 France

4. Pathology DepartmentBeaujon Hospital Assistance Publique‐Hôpitaux de Paris Clichy F‐92110 France

5. Hepatobiliary Surgery DepartmentBeaujon Hospital Assistance Publique‐Hôpitaux de Paris Clichy F‐92110 France

Funder

Ligue Contre le Cancer

Institut National Du Cancer

Fondation pour la Recherche Médicale

Publisher

Wiley

Subject

Clinical Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prca.201800128

Reference40 articles.

1. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

2. Cholangiocarcinoma

3. Cholangiocarcinoma — evolving concepts and therapeutic strategies

4. cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation

5. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bile Composition - which Components Can Have Clinical Significance? A Review of the Literature;Journal of Gastrointestinal and Liver Diseases;2023-04-01

2. Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma;Hepatology;2023-01-03

3. Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study;Molecules;2022-09-11

4. In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma;Cancer Management and Research;2022-09

5. Selected by bioinformatics and molecular docking analysis, Dhea and 2–14,15-Eg are effective against cholangiocarcinoma;PLOS ONE;2022-02-03